Ausgabe 4/2019
Inhalt (17 Artikel)
JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-9. Extranodal NK/T-cell lymphoma, nasal type (ENKL)
Motoko Yamaguchi, Ritsuro Suzuki
Comparison of minimal residual disease detection in multiple myeloma by SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry
Hiroyuki Takamatsu, Takeshi Yoroidaka, Momoko Fujisawa, Kazuya Kobori, Masako Hanawa, Takeshi Yamashita, Ryoichi Murata, Mikio Ueda, Shinji Nakao, Kosei Matsue
Atypical SIFD with novel TRNT1 mutations: a case study on the pathogenesis of B-cell deficiency
Eri Kumaki, Keisuke Tanaka, Kohsuke Imai, Yuki Aoki-Nogami, Akira Ishiguro, Satoshi Okada, Hirokazu Kanegane, Fumihiko Ishikawa, Tomohiro Morio
Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation
Shoko Furukawa, Keiji Nogami, Kenichi Ogiwara, Midori Shima
Clinical features at transformation in adult T-cell leukemia–lymphoma with smoldering and chronic types
Hiroaki Taniguchi, Yoshitaka Imaizumi, Yumi Takasaki, Jun Nakashima, Takeharu Kato, Hidehiro Itonaga, Shinya Sato, Yasushi Sawayama, Koji Ando, Hiroo Hasegawa, Tomoko Hata, Yukiyoshi Moriuchi, Kunihiro Tsukasaki, Yasushi Miyazaki
Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study)
Hirokazu Murakami, Tetsuhiro Kasamatsu, Jun Murakami, Toru Kiguchi, Takeshi Kanematsu, Daisuke Ogawa, Hiroyuki Takamatsu, Hiroshi Handa, Shuji Ozaki, Hirokazu Miki, Takeshi Takahashi, Takaaki Takeo, Tatsuya Yamauchi, Takanobu Morishita, Hiroshi Kosugi, Kazuyuki Shimizu
Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia
Nahoko Hatsumi, Shuichi Miyawaki, Takahiro Yamauchi, Akihiro Takeshita, Norio Komatsu, Noriko Usui, Yukihiro Arai, Fumihiro Ishida, Takeshi Morii, Yasuhiko Kano, Michinori Ogura, Shinichiro Machida, Kazuhiro Nishii, Sumihisa Honda, Kazunori Ohnishi, Tomoki Naoe
Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system
Masahiro Kizaki, Naoto Takahashi, Noriyoshi Iriyama, Shinichiro Okamoto, Takaaki Ono, Noriko Usui, Koiti Inokuchi, Chiaki Nakaseko, Mineo Kurokawa, Masahiko Sumi, Fumihiko Nakamura, Tatsuya Kawaguchi, Ritsuro Suzuki, Kazuhito Yamamoto, Kazunori Ohnishi, Itaru Matsumura, Tomoki Naoe, M. Kizaki, S. Mori, T. Nemoto, M. Sagawa, T. Tabayashi, M. Tokuhira, T. Tomikawa, R. Watanabe, Y. Hatta, Y. Inoue, N. Iriyama, S. Kobayashi, Y. Kobayashi, D. Kurita, D. Karigane, H. Kasahara, Y. Koda, Y. Miyakawa, K. Murakami, S. Okamoto, S. Watanuki, T. Ono, Y. Nagata, A. Takeshita, N. Takahashi, Y. Kameoka, T. Yoshioka, S. Takahashi, N. Usui, K. Dan, K. Inokuchi, K. Nakamura, D. Abe, C. Nakaseko, C. Ohwada, E. Sakaida, N. Shimizu, M. Takeuchi, S. Arai, Y. Kogure, A. Koya, Y. Masamoto, A. Masuda, K. Nakazaki, K. Toyama, Y. Hiroshima, N. Ichikawa, T. Kirihara, H. Kobayashi, I. Shimizu, M. Sumi, T. Ueki, S. Hagiwara, R. Hirai, T. Miwa, F. Nakamura, M. Nakamura, M. Takeshita, A. Tanimura, F. Hayakawa, Y. Ishikawa, H. Kiyoi, M. Murata, A. Tomita, T. Kurokawa, C. Sugimori, A. Arai, O. Miura, M. Yamamoto, K. Imai, N. Kobayashi, K. Minauchi, M. Obara, S. Ota, T. Ikezoe, M. Mori, M. Sakai, A. Taniguchi, K. Togitani, H. Hayakawa, T. Kajiguchi, S. Kamoshita, E. Otsuka, A. Nishida, M. Saburi, Y. Saburi, H. Iida, C. Kato, Y. Kojima, H. Ohashi, Y. Miyata, K. Sugimoto, H. Yamamoto, T. Yokozawa, T. Kamae, J. Kuyama, H. Mitsui, Y. Morikawa, Y. Uchida, T. Ashida, C. Hirase, K. Kawanishi, I. Matsumura, J. Miyatake, Y. Morita, T. Sano, T. Shimada, H. Tanaka, Y. Taniguchi, Y. Tatsumi, K. Yamaguchi, F. Ishida, K. Momose, H. Nakazawa, S. Nishina, H. Sakai, N. Sekiguchi, Y. Ito, K. Ohyashiki, T. Tauchi, T. Hata, Y. Imaizumi, D. Imanishi, H. Itonaga, J. Makiyama, Y. Sawayama, J. Taguchi, M. Taguchi, H. Taniguchi, G. Eguchi, M. Matsuda, N. Yamairi, N. Fukushima, K. Ozeki, A. Kohno, T. Sakura, S. Takada, T. Kobayashi, H. Sakamaki, N. Asou, T. Kawaguchi, T. Kiguchi, T. Masunari, N. Sezaki, M. Iino, K. Morinaga, K. Ikeda, K. Ogawa, H. Noji, H. Iwasaki, K. Takenaka, T. Miyamoto, H. Handa, H. Murakami, N. Tsukamoto, T. Eto, H. Henzan, Y. Kamitsuji, N. Uoshima, M. Hagihara, H. Takahashi, N. Emi, M. Okamoto, K. Kawakami, M. Waki, N. Fukuhara, H. Harigae, T. Murayama, I. Mizuno, H. Okumura, Y. Tsutsumi, K. Usuki, T. Fujisaki, Y. Maeda, Y. Suehiro, H. Suzushima, K. Yamamoto, Y. Kanakura, K. Nagasaki, H. Muto, S. Fujisawa, M. Adachi, A. Mugitani, S. Yamasaki, Y. Adachi, T. Kamimura, Y. Takamatsu, T. Ryu, S. Chiba, K. Ohishi, K. Suzuki, D. Ogawa, H. Mihara, H. Fujita, K. Kubo, A. Yokota, K. Miyamura, C. Yoshida, S. Nakachi, T. Myojyo, A. Kitabayashi, J. Suzumiya, M. Hino, A. Wakita, T. Shibata, T. Takahashi, H. Takamatsu, K. Fujimaki, K. Tajika, M. Mita, Y. Terui, M. Ito, T. Yamane, T. Yamauchi, Y. Kohara, C. Takebayashi, A. Inagaki, M. Tsuji, H. Shinzaki, Y. Moriuchi, M. Ishikawa, K. Miyazaki, E. Shima, N. Kinugawa
Optimal dosage of methotrexate for GVHD prophylaxis in umbilical cord blood transplantation
Yoshitaka Adachi, Kazutaka Ozeki, Shun Ukai, Ken Sagou, Nobuaki Fukushima, Akio Kohno
Prognostic values of increased B7 family proteins in haploidentical hematopoietic stem cell transplantation patients with aGVHD
Biqi Zhou, Tanzhen Wang, Lei Lei, Yutong Lu, Li Zhang, Xiaowen Tang, Huiying Qiu, Aining Sun, Xueguang Zhang, Yang Xu, Depei Wu
Feasibility of salvage cord blood transplantation using a fludarabine, melphalan, and low-dose anti-thymocyte globulin conditioning regimen
Takumi Hoshino, Satoru Takada, Nahoko Hatsumi, Toru Sakura
Comparison of neutropenia profiles in different treatment protocols for acute myeloid leukemia using the D-index
Yasufumi Kawasaki, Shun-ichi Kimura, Hirofumi Nakano, Kiyomi Mashima, Yuya Shirato, Shin-ichiro Kawaguchi, Yumiko Toda, Shin-ichi Ochi, Takashi Nagayama, Daisuke Minakata, Ryoko Yamasaki, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Shin-ichiro Fujiwara, Ken Ohmine, Shinichi Kako, Kazuo Muroi, Yoshinobu Kanda
Discontinuation of l-asparaginase and poor response to prednisolone are associated with poor outcome of ETV6-RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia
Ikuya Usami, Toshihiko Imamura, Yoshihiro Takahashi, So-ichi Suenobu, Daiichiro Hasegawa, Yoshiko Hashii, Takao Deguchi, Tsukasa Hori, Akira Shimada, Koji Kato, Eturou Ito, Akiko Moriya-Saito, Hirohide Kawasaki, Hiroki Hori, Keiko Yumura-Yagi, Junichi Hara, Atsushi Sato, Keizo Horibe
Hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma
Naoto Fujita, Ryoji Kobayashi, Yoshiko Atsuta, Fuminori Iwasaki, Junji Suzumiya, Yoji Sasahara, Masami Inoue, Katsuyoshi Koh, Tsukasa Hori, Hiroaki Goto, Tatsuo Ichinohe, Yoshiko Hashii, Koji Kato, Ritsuro Suzuki, Tetsuo Mitsui
Prophylaxis and treatment with mycophenolate mofetil in children with graft-versus-host disease undergoing allogeneic hematopoietic stem cell transplantation: a nationwide survey in Japan
Nozomu Kawashima, Minako Iida, Ritsuro Suzuki, Takahiro Fukuda, Yoshiko Atsuta, Yoshiko Hashii, Masami Inoue, Masao Kobayashi, Hiromasa Yabe, Keiko Okada, Souichi Adachi, Yuki Yuza, Keisei Kawa, Koji Kato
A case of AITL complicated by EBV-positive B cell and monoclonal plasma cell proliferation and effectively treated with lenalidomide
Wataru Kishimoto, Yoko Takiuchi, Yoshiki Nakae, Sumie Tabata, Akiko Fukunaga, Naomi Matsuzaki, Yoshiaki Yuba, Toshiyuki Kitano, Nobuyoshi Arima
Correction to: Comparison of minimal residual disease detection in multiple myeloma by SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry
Hiroyuki Takamatsu, Takeshi Yoroidaka, Momoko Fujisawa, Kazuya Kobori, Masako Hanawa, Takeshi Yamashita, Ryoichi Murata, Mikio Ueda, Shinji Nakao, Kosei Matsue